GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Jan. 29, 2022

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

2. GOODWILL AND INTANGIBLE ASSETS

The Company’s goodwill balance as of January 29, 2022 and January 30, 2021 was $3,076. Gross goodwill and accumulated impaired losses were $5,737 and $2,661, respectively, as of January 29, 2022 and January 30, 2021.

Testing for impairment is performed annually, or on an interim basis upon the occurrence of a triggering event or a change in circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The annual evaluation of goodwill and indefinite-lived intangible assets was performed during the fourth quarter of 2021, 2020 and 2019 and did not result in impairment.

The following table summarizes the Company’s intangible assets balance through January 29, 2022:

	2021				2020
	Gross carrying		Accumulated		Gross carrying		Accumulated
	amount		amortization(1)		amount		amortization(1)
Definite-lived pharmacy prescription files	$	317	$	(199)	$	315	$	(167)
Definite-lived customer relationships		186		(160)		186		(143)
Definite-lived other		111		(88)		110		(78)
Indefinite-lived trade name		685		—		685		—
Indefinite-lived liquor licenses		90		—		89		—
Total	$	1,389	$	(447)	$	1,385	$	(388)

(1) Pharmacy prescription files are amortized to merchandise costs, customer relationships are amortized to depreciation and amortization expense and other intangibles are amortized to OG&A expense and depreciation and amortization expense.

Amortization expense associated with intangible assets totaled approximately $59, $67 and $85, during fiscal years 2021, 2020 and 2019, respectively. Future amortization expense associated with the net carrying amount of definite-lived intangible assets for the years subsequent to 2021 is estimated to be approximately:

2022	$	51
2023		39
2024		34
2025		31
2026		10
Thereafter		2
Total future estimated amortization associated with definite-lived intangible assets	$	167